COPJ moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 30 of 32 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COPJ as a result. In 49 of 60 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The 10-day moving average for COPJ crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COPJ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for COPJ entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for COPJ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where COPJ advanced for three days, in 209 of 235 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
COPJ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The RSI Indicator for MTAL moved into overbought territory on October 22, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
MTAL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MTAL as a result. In 35 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 35%.
The Moving Average Convergence Divergence Histogram (MACD) for MTAL turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 20 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 41%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTAL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
The Aroon Indicator for MTAL entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. MTAL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.372) is normal, around the industry mean (-542.660). P/E Ratio (-3.087) is within average values for comparable stocks, (117.432). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (15.932). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks.
The Tickeron Profit vs. Risk Rating rating for this company is 95 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTAL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock better than average.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
| COPJ | MTAL | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 41% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 35% |
| MACD ODDS (%) | N/A | 1 day ago 41% |
| TrendWeek ODDS (%) | 1 day ago 85% | 1 day ago 42% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 43% |
| Advances ODDS (%) | 18 days ago 89% | N/A |
| Declines ODDS (%) | 1 day ago 83% | 1 day ago 57% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 57% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 32% |
A.I.dvisor indicates that over the last year, COPJ has been loosely correlated with MTAL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if COPJ jumps, then MTAL could also see price increases.
| Ticker / NAME | Correlation To COPJ | 1D Price Change % | ||
|---|---|---|---|---|
| COPJ | 100% | -5.80% | ||
| MTAL - COPJ | 59% Loosely correlated | -0.45% | ||
| NAK - COPJ | 52% Loosely correlated | -6.14% | ||
| CVV - COPJ | 30% Poorly correlated | -0.26% | ||
| SLS - COPJ | 23% Poorly correlated | -6.51% | ||
| OM - COPJ | 17% Poorly correlated | +2.96% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NURE | 31.69 | 0.57 | +1.82% |
| Nuveen Short-Term REIT ETF (NURE) | |||
| DFAR | 25.03 | 0.36 | +1.46% |
| DFA Real Estate Securities Portfolio: ETF Class Shares (DFAR) | |||
| ZTR | 6.46 | 0.03 | +0.47% |
| Virtus Total Return Fund | |||
| ITDE | 39.90 | -0.34 | -0.84% |
| iShares LifePath Target Date 2045 ETF USD (ITDE) | |||
| WLDU | 16.62 | -0.54 | -3.14% |
| Leverage Shares 2x Long World Stock Daily ETF | |||